Members |
targetComponentId |
bifasiskt humant isofaninsulin 40/60, 100 E/ml, injektionsvätska, lösning, cylinderampull 1,5 ml |
Product containing precisely human isophane insulin 60 unit/1 milliliter and recombinant human regular insulin 40 unit/1 milliliter conventional release suspension for injection (clinical drug) |
bifasiskt humant isofaninsulin 40/60, 100 E/ml, injektionsvätska, lösning, cylinderampull 3 ml |
Product containing precisely human isophane insulin 60 unit/1 milliliter and recombinant human regular insulin 40 unit/1 milliliter conventional release suspension for injection (clinical drug) |
bifasiskt humant isofaninsulin 40/60, 100 E/ml, injektionsvätska, lösning, förfylld penna 3 ml |
Product containing precisely human isophane insulin 60 unit/1 milliliter and recombinant human regular insulin 40 unit/1 milliliter conventional release suspension for injection (clinical drug) |
bifasiskt humant isofaninsulin 50/50, 100 E/ml, injektionsvätska, lösning, cylinderampull 1,5 ml |
Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug) |
bifasiskt humant isofaninsulin 50/50, 100 E/ml, injektionsvätska, lösning, flaska 10 ml |
Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug) |
bifasiskt humant isofaninsulin 50/50, 100 E/ml, injektionsvätska, lösning, cylinderampull 3 ml |
Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug) |
bifasiskt humant isofaninsulin 50/50, 100 E/ml, injektionsvätska, lösning, förfylld penna 3 ml |
Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug) |
bifasiskt humant isofaninsulin 50/50, 100 E/ml, injektionsvätska, lösning, flaska 5 ml |
Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug) |
bifasiskt porcint isofaninsulin 30/70, 100 E/ml, injektionsvätska, lösning, flaska 10 ml |
Product containing precisely porcine isophane insulin 70 unit/1 milliliter and porcine regular insulin 30 unit/1 milliliter conventional release suspension for injection (clinical drug) |
bifasiskt lisproinsulin 25/75, 100 E/ml, injektionsvätska, lösning, cylinderampull 3 ml |
Product containing precisely insulin lispro 25 unit/1 milliliter and insulin lispro protamine 75 unit/1 milliliter conventional release solution for injection (clinical drug) |
bifasiskt lisproinsulin 25/75, 100 E/ml, injektionsvätska, lösning, förfylld penna 3 ml |
Product containing precisely insulin lispro 25 unit/1 milliliter and insulin lispro protamine 75 unit/1 milliliter conventional release solution for injection (clinical drug) |
bifasiskt lisproinsulin 50/50, 100 E/ml, injektionsvätska, lösning, förfylld penna 3 ml |
Product containing precisely insulin lispro 50 unit/1 milliliter and insulin lispro protamine 50 unit/1 milliliter conventional release solution for injection (clinical drug) |
Insulin isophane biphasic human 10/90 100units/ml injection 1.5ml cartridge |
Product containing precisely human isophane insulin 90 unit/1 milliliter and recombinant human regular insulin 10 unit/1 milliliter conventional release suspension for injection (clinical drug) |
Insulin isophane biphasic human 10/90 100units/ml injection 3ml pre-filled disposable injection device |
Product containing precisely human isophane insulin 90 unit/1 milliliter and recombinant human regular insulin 10 unit/1 milliliter conventional release suspension for injection (clinical drug) |
Insulin isophane biphasic human 15/85 100units/ml injection 5ml vial |
Product containing precisely human isophane insulin 85 unit/1 milliliter and recombinant human regular insulin 15 unit/1 milliliter conventional release suspension for injection (clinical drug) |
Insulin isophane biphasic human 20/80 100units/ml injection 3ml cartridge |
Product containing precisely human isophane insulin 80 unit/1 milliliter and recombinant human regular insulin 20 unit/1 milliliter conventional release suspension for injection (clinical drug) |
Insulin isophane biphasic human 20/80 100units/ml injection 3ml pre-filled disposable injection device |
Product containing precisely human isophane insulin 80 unit/1 milliliter and recombinant human regular insulin 20 unit/1 milliliter conventional release suspension for injection (clinical drug) |
Insulin isophane biphasic human 25/75 100units/ml injection 3ml pre-filled disposable injection device |
Product containing precisely human isophane insulin 75 unit/1 milliliter and recombinant human regular insulin 25 unit/1 milliliter conventional release suspension for injection (clinical drug) |
Insulin isophane biphasic human 25/75 100units/ml injection 5ml vial |
Product containing precisely human isophane insulin 75 unit/1 milliliter and recombinant human regular insulin 25 unit/1 milliliter conventional release suspension for injection (clinical drug) |
Insulin isophane biphasic human 30/70 100units/ml injection 10ml vial |
Product containing precisely human isophane insulin 70 unit/1 milliliter and recombinant human regular insulin 30 unit/1 milliliter conventional release solution for injection (clinical drug) |
Insulin isophane biphasic human 30/70 100units/ml injection 3ml pre-filled disposable injection device |
Product containing precisely human isophane insulin 70 unit/1 milliliter and recombinant human regular insulin 30 unit/1 milliliter conventional release solution for injection (clinical drug) |
Insulin isophane biphasic human 40/60 100units/ml injection 3ml cartridge |
Product containing precisely human isophane insulin 60 unit/1 milliliter and recombinant human regular insulin 40 unit/1 milliliter conventional release suspension for injection (clinical drug) |
Insulin isophane biphasic human 40/60 100units/ml injection 3ml pre-filled disposable injection device |
Product containing precisely human isophane insulin 60 unit/1 milliliter and recombinant human regular insulin 40 unit/1 milliliter conventional release suspension for injection (clinical drug) |
Insulin isophane biphasic human 50/50 100units/ml injection 10ml vial |
Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug) |
Insulin isophane biphasic human 50/50 100units/ml injection 3ml cartridge |
Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug) |
Insulin isophane biphasic human 50/50 100units/ml injection 3ml pre-filled disposable injection device |
Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug) |
Insulin isophane biphasic human 50/50 100units/ml injection 5ml vial |
Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug) |
Insulin isophane biphasic porcine 30/70 100units/ml injection 10ml vial |
Product containing precisely porcine isophane insulin 70 unit/1 milliliter and porcine regular insulin 30 unit/1 milliliter conventional release suspension for injection (clinical drug) |
bovint isofaninsulin, 100 E/ml, injektionsvätska, lösning, cylinderampull 1,5 ml |
Bovine isophane insulin 100 unit/mL suspension for injection |
porcint isofaninsulin, 100 E/ml, injektionsvätska, lösning, cylinderampull 1,5 ml |
Product containing precisely porcine isophane insulin 100 unit/1 milliliter conventional release suspension for injection (clinical drug) |
porcint isofaninsulin, 100 E/ml, injektionsvätska, lösning, flaska 10 ml |
Product containing precisely porcine isophane insulin 100 unit/1 milliliter conventional release suspension for injection (clinical drug) |
Insulin isophane porcine 100units/ml injection 10ml vial |
Product containing precisely porcine isophane insulin 100 unit/1 milliliter conventional release suspension for injection (clinical drug) |
Insulin lispro biphasic (recombinant human insulin analogue) human 25/75 100units/ml injection 3ml cartridge |
Product containing precisely insulin lispro 25 unit/1 milliliter and insulin lispro protamine 75 unit/1 milliliter conventional release solution for injection (clinical drug) |
porcint lösligt insulin, 100 E/ml, injektionsvätska, lösning, cylinderampull 1,5 ml |
Product containing precisely porcine regular insulin 100 unit/1 milliliter conventional release solution for injection (clinical drug) |
biverkning av amorf zinkinsulinsuspension |
Adverse reaction to zinc insulin |
biverkning av kristallin zinkinsulinsuspension |
Adverse reaction to zinc insulin |
allergi mot kristallin zinkinsulinsuspension |
Allergy to zinc insulin |
biverkning av zinkinsulinsuspension |
Adverse reaction to zinc insulin |
Intact parathyrin |
Parathyroid hormone |
integrerad muskuloskeletal frigöring |
Osteopathic combined treatment method (procedure) |
Intentional X-ray contrast media overdose |
Intentional X-ray diagnostic contrast media overdose |
Intentional X-ray contrast media poisoning |
Intentional X-ray diagnostic contrast media overdose |
avsiktlig överdos av disulfiram |
Intentional disulfiram overdose (disorder) |
avsiktlig disulfiramförgiftning |
Intentional disulfiram poisoning (disorder) |
Intentional chlorprothixene overdose |
Intentional chlorprothixene overdose (disorder) |
avsiktlig överdos av natriumvalproat |
Intentional valproate overdose (disorder) |
Intentional pesticide product overdose |
Intentional pesticide product poisoning |
avsiktlig överdos av natriumfusidat |
Intentional fusidic acid overdose |
avsiktlig warfarinöverdos |
Intentional warfarin overdose (disorder) |
Intentional zuclopenthixol overdose |
Intentional chlorprothixene overdose (disorder) |
Interdigital pilonidal sinus |
Barber's pilonidal sinus |
interferon alfa-2b 10 miljoner IE, pulver och vätska till injektionslösning, flaska |
Interferon alfa-2b only product in parenteral dose form |
interferon alfa-2b 10 miljoner IE, pulver till injektionsvätska, lösning, flaska |
Interferon alfa-2b only product in parenteral dose form |
interferon alfa-2b 10 miljoner IE/ml, injektionsvätska, lösning, flaska 2,5 ml |
Product containing precisely interferon alfa-2b 10 million unit/1 milliliter conventional release solution for injection (clinical drug) |
interferon alfa-2b 18 miljoner IE/flaska, lösning |
Interferon alfa-2b only product |
Interferon alfa-2b 18million/iu solution |
Interferon alfa-2b only product |
Interferon alfa-2b 18mu/vial |
Interferon alfa-2b only product |
interferon alfa-2b 25 miljoner IE/flaska, lösning |
Interferon alfa-2b only product |
interferon alfa-2b 3 miljoner IE/flaska, lösning |
Interferon alfa-2b only product |
interferon alfa-2b 30 miljoner IE, lösning |
Interferon alfa-2b only product |
interferon alfa-2b 3 miljoner IE, pulver och vätska till injektionslösning, flaska |
Interferon alfa-2b only product in parenteral dose form |
interferon alfa-2b 3 miljoner IE, pulver till injektionsvätska, lösning, flaska |
Interferon alfa-2b only product in parenteral dose form |
interferon alfa-2b 5 miljoner IE/flaska, lösning |
Interferon alfa-2b only product |
interferon alfa-2b 5 miljoner IE, pulver och vätska till injektionslösning, flaska |
Interferon alfa-2b only product in parenteral dose form |
interferon alfa-2b 5 miljoner IE, pulver till injektionsvätska, lösning, flaska |
Interferon alfa-2b only product in parenteral dose form |
interferon alfa-2b 60 miljoner IE, lösning |
Interferon alfa-2b only product |
interferon alfa-n3 från humana leukocyter 5 miljoner enheter/ml, injektionsvätska, lösning, flaska 1 ml |
Product containing precisely interferon alfa-n3 5 million unit/1 milliliter conventional release solution for injection (clinical drug) |
interferon beta-1a 12 miljoner IE/ml, injektionslösning, förfylld spruta 0,5 ml |
Interferon beta-1a 30 microgram/mL solution for injection |
interferon beta-1a 24 miljoner IE/ml, injektionslösning, förfylld spruta 0,5 ml |
Interferon beta-1a 24 million unit/mL solution for injection |
Interferon beta-1a 30mcg/vial injection |
Product containing precisely interferon beta-1a 30 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
interferon beta-1a 30 mikrogram/injektionsflaska, injektionsvätska, lösning |
Product containing precisely interferon beta-1a 30 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
interferon beta-1a 6 miljoner IE, pulver och vätska till injektionslösning, flaska |
Interferon beta-1a only product in parenteral dose form |
interferon beta-1a 6 miljoner IE, pulver till injektionsvätska, lösning, flaska |
Interferon beta-1a only product in parenteral dose form |
interferon beta 1-b 100 mikrogram, injektionsvätska, lösning |
Product containing only interferon beta-1b in parenteral dose form (medicinal product form) |
interferon beta-1b 8 miljoner IE, pulver och vätska till injektionslösning, flaska |
Product containing only interferon beta-1b in parenteral dose form (medicinal product form) |
interferon beta-1b 8 miljoner IE, pulver till injektionsvätska, lösning, flaska |
Product containing only interferon beta-1b in parenteral dose form (medicinal product form) |
interimsrapport |
Interim report (record artifact) |
intermediär faktor VIII-fraktion, 250 IE, pulver och vätska till injektionslösning, flaska |
Coagulation factor VIII only product |
intermediär faktor VIII-fraktion, 500 IE, pulver och vätska till injektionslösning, flaska |
Coagulation factor VIII only product |
Angiography of internal carotid arteries, bilateral |
Angiography of cervicocerebral arteries |
Intermediate lobe of right lung |
Structure of middle lobe of right lung (body structure) |
intermediär metaboliserare på grund av cytokrom p450, variant CYP2C19 |
CYP2C19 intermediate metabolizer |
intermediär metaboliserare på grund av cytokrom P450, variant CYP2D6 |
Cytochrome P450 family 2 subfamily D member 6 intermediate metabolizer (finding) |
Internal fixation of mandible with arch bars |
External fixation of mandible with arch bars (procedure) |
intern fixering av underkäken med bågstänger |
External fixation of mandible with arch bars (procedure) |
Internal granuloma of pulp |
Internal resorption of tooth |
intern migration |
Transuterine migration (finding) |
Internal resorption of crown of tooth |
Internal resorption of tooth |
cervixcancer FIGO-stadium 0 |
FIGO stage finding for cervical carcinoma |
Intersphincteric anal canal dissection |
Dissection - action |
Intertarsal joint |
Intertarsal joint structure |
Intervertebral disc extrusion |
Intervertebral disc prolapse |
Intestinal infection due to Enterobacter aerogenes |
Intestinal infection caused by Klebsiella aerogenes |
Intestinal infection due to other organisms |
Infectious enteritis of intestine |
Intra-amniotic fetal infection |
Intra-amniotic infection of fetus |
Intracranial hemorrhage following injury with open intracranial wound and unspecified state of consciousness |
Intracranial hemorrhage following injury with open intracranial wound |
intracystiskt karcinom |
Encapsulated papillary carcinoma (morphologic abnormality) |
intraduktalt carcinoma in situ |
Non-infiltrating intraductal carcinoma |
intraduktal papillär-mucinös tumör med måttlig dysplasi |
Intraductal papillary-mucinous adenoma (morphologic abnormality) |
allergi mot intramuskulärt testosteron |
Allergy to testosterone |
Intranasal intubation of lacrimal apparatus for tear drainage |
Intranasal intubation of lacrimal drainage system for tear drainage (procedure) |